Xue Jing

1.3k total citations · 1 hit paper
46 papers, 854 citations indexed

About

Xue Jing is a scholar working on Physiology, Surgery and Molecular Biology. According to data from OpenAlex, Xue Jing has authored 46 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Physiology, 13 papers in Surgery and 11 papers in Molecular Biology. Recurrent topics in Xue Jing's work include Nutrition and Health in Aging (12 papers), Helicobacter pylori-related gastroenterology studies (6 papers) and Inflammatory Bowel Disease (6 papers). Xue Jing is often cited by papers focused on Nutrition and Health in Aging (12 papers), Helicobacter pylori-related gastroenterology studies (6 papers) and Inflammatory Bowel Disease (6 papers). Xue Jing collaborates with scholars based in China, Denmark and Italy. Xue Jing's co-authors include Xueli Ding, Yanan Yu, Xinjuan Kong, Zibin Tian, Zibin Tian, Yingjie Guo, Lin Yang, Zhen Sun, Xiaoyu Li and Zibin Tian and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Hazardous Materials.

In The Last Decade

Xue Jing

38 papers receiving 833 citations

Hit Papers

Global Primary Antibiotic Resistance Rate of Helicobacter... 2024 2026 2025 2024 10 20 30

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xue Jing China 15 299 209 182 123 121 46 854
Rina Kato Japan 20 357 1.2× 217 1.0× 141 0.8× 60 0.5× 86 0.7× 52 1.1k
Dimitris Kounatidis Greece 16 341 1.1× 109 0.5× 214 1.2× 69 0.6× 254 2.1× 65 830
Xueli Ding China 12 223 0.7× 131 0.6× 84 0.5× 65 0.5× 79 0.7× 41 550
Sina M. Coldewey Germany 19 372 1.2× 130 0.6× 94 0.5× 56 0.5× 229 1.9× 57 1.0k
Lulu Liu China 17 235 0.8× 194 0.9× 100 0.5× 122 1.0× 295 2.4× 83 946
Marta Borges‐Canha Portugal 16 300 1.0× 256 1.2× 117 0.6× 67 0.5× 187 1.5× 50 897
Weiming Zhu China 16 297 1.0× 442 2.1× 221 1.2× 115 0.9× 114 0.9× 39 1.0k
Gabriela Angélica Martínez‐Nava Mexico 17 353 1.2× 104 0.5× 190 1.0× 78 0.6× 138 1.1× 54 977
Kees Meijer Netherlands 8 262 0.9× 81 0.4× 184 1.0× 48 0.4× 133 1.1× 16 646
Cristhiane Fávero de Aguiar Brazil 11 396 1.3× 85 0.4× 184 1.0× 39 0.3× 118 1.0× 19 829

Countries citing papers authored by Xue Jing

Since Specialization
Citations

This map shows the geographic impact of Xue Jing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Jing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Jing more than expected).

Fields of papers citing papers by Xue Jing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue Jing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Jing. The network helps show where Xue Jing may publish in the future.

Co-authorship network of co-authors of Xue Jing

This figure shows the co-authorship network connecting the top 25 collaborators of Xue Jing. A scholar is included among the top collaborators of Xue Jing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue Jing. Xue Jing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhou, Meiyi, Xue Jing, Bin Liu, et al.. (2025). Clinical study of PLA2R epitope spreading for predicting proteinuria remission in primary membranous nephropathy. Frontiers in Immunology. 16. 1685738–1685738.
3.
Yu, Yanhui, et al.. (2025). Antibiotic heteroresistance: an important factor in the failure of Helicobacter Pylori eradication. Critical Reviews in Microbiology. 51(6). 1330–1345. 2 indexed citations
4.
Zhao, Lihua, Daiwen Chen, Yaru Xu, et al.. (2025). Prevalence and Diagnosis of Malnutrition in Patients with Chronic Kidney Disease: Evaluating the Value of NRS2002 and SGA Scores. Kidney & Blood Pressure Research. 50(1). 513–522.
5.
Zhao, Xiaoqi, M. Bai, Xue Jing, et al.. (2024). High‐Performance Engineered Composites Biofabrication Using Fungi. Small. 20(25). e2309171–e2309171. 4 indexed citations
6.
Jiang, Yueping, Ge Guan, Xueguo Sun, et al.. (2024). Prognostic Value of Myosteatosis and Creatinine-to-Cystatin C Ratio in Patients with Pancreatic Cancer Who Underwent Radical Surgery. Annals of Surgical Oncology. 31(5). 2913–2924. 3 indexed citations
7.
Zhou, Le‐Ting, Xue Jing, Zhijian Zhang, et al.. (2024). Predictive value of the domain specific PLA2R antibodies for clinical remission in patients with primary membranous nephropathy: A retrospective study. PLoS ONE. 19(5). e0302100–e0302100. 6 indexed citations
8.
Huang, Longchang, Yupeng Zhang, Yifan Shi, et al.. (2023). Rapid assessment of malnutrition based on GLIM diagnosis in Crohn’s disease. Frontiers in Nutrition. 10. 1236036–1236036. 3 indexed citations
9.
Chen, Jianwei, et al.. (2023). Effect of fucoidan on gut microbiota and its clinical efficacy in Helicobacter pylori eradication: A randomized controlled trial. Journal of Digestive Diseases. 24(8-9). 461–471. 10 indexed citations
10.
Zhang, Li, Xuejin Gao, Cong Dai, et al.. (2023). Impact of malnutrition and sarcopenia on quality of life in patients with inflammatory bowel disease: A multicentre study. Journal of Cachexia Sarcopenia and Muscle. 14(6). 2663–2675. 21 indexed citations
11.
Liu, Sifan, et al.. (2022). Low Muscle Mass Is Associated with Readmission for Inflammatory Bowel Disease. The Turkish Journal of Gastroenterology. 34(2). 108–117. 3 indexed citations
12.
Ding, Xueli, et al.. (2022). Sarcopenia is associated with poor clinical outcomes in patients with inflammatory bowel disease: a prospective cohort study. Annals of Translational Medicine. 10(6). 367–367. 28 indexed citations
13.
14.
Wang, Dawei, Xueying Zhang, Xueli Ding, et al.. (2020). MicroRNA-498 inhibits the proliferation, migration and invasion of gastric cancer through targeting BMI-1 and suppressing AKT pathway. Human Cell. 33(2). 366–376. 14 indexed citations
15.
Cheng, Yong, Tianhui Chen, Xia Yang, Xue Jing, & Jianjun Chen. (2019). Atractylon induces apoptosis and suppresses metastasis in hepatic cancer cells and inhibits growth in vivo. SHILAP Revista de lepidopterología. 2 indexed citations
16.
Guo, Yingjie, et al.. (2019). Endoscopic Removal of Gastrointestinal Stromal Tumors in the Stomach: A Single-Center Experience. Gastroenterology Research and Practice. 2019. 1–9. 7 indexed citations
18.
Piao, Shilong, Fangjian Guo, Xue Jing, et al.. (2012). Increased expression of CD147 and MMP-9 is correlated with poor prognosis of salivary duct carcinoma. Journal of Cancer Research and Clinical Oncology. 138(4). 627–635. 41 indexed citations
19.
Hu, He-Ping, Yuxiong Feng, Shi Jie, et al.. (2010). Characterisation of a novel cell line (CSQT-2) with high metastatic activity derived from portal vein tumour thrombus of hepatocellular carcinoma. British Journal of Cancer. 102(11). 1618–1626. 51 indexed citations
20.
Jl, Liu, et al.. (2007). [Expression and biological significance of HPA and HIF-1alpha in human esophageal squamous cell carcinoma].. PubMed. 29(9). 689–92. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026